nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—CYP2D6—Fingolimod—multiple sclerosis	0.0949	0.214	CbGbCtD
Escitalopram—CYP3A4—Fingolimod—multiple sclerosis	0.0603	0.136	CbGbCtD
Escitalopram—CYP2C19—Prednisone—multiple sclerosis	0.0487	0.11	CbGbCtD
Escitalopram—CYP3A4—Methylprednisolone—multiple sclerosis	0.0389	0.0878	CbGbCtD
Escitalopram—CYP2C19—Dexamethasone—multiple sclerosis	0.0304	0.0687	CbGbCtD
Escitalopram—CYP3A4—Triamcinolone—multiple sclerosis	0.0295	0.0666	CbGbCtD
Escitalopram—CYP3A4—Mitoxantrone—multiple sclerosis	0.0284	0.0641	CbGbCtD
Escitalopram—CYP3A4—Betamethasone—multiple sclerosis	0.0253	0.0571	CbGbCtD
Escitalopram—CYP3A4—Prednisolone—multiple sclerosis	0.0249	0.0563	CbGbCtD
Escitalopram—CYP3A4—Prednisone—multiple sclerosis	0.0236	0.0532	CbGbCtD
Escitalopram—CYP2D6—Dexamethasone—multiple sclerosis	0.0231	0.0522	CbGbCtD
Escitalopram—CYP3A4—Dexamethasone—multiple sclerosis	0.0147	0.0332	CbGbCtD
Escitalopram—SLC6A3—nerve—multiple sclerosis	0.00372	0.0946	CbGeAlD
Escitalopram—SLC6A2—nerve—multiple sclerosis	0.003	0.0764	CbGeAlD
Escitalopram—SLC6A3—brainstem—multiple sclerosis	0.0016	0.0406	CbGeAlD
Escitalopram—HTR2C—brainstem—multiple sclerosis	0.00154	0.0393	CbGeAlD
Escitalopram—SLC6A4—brainstem—multiple sclerosis	0.00146	0.0372	CbGeAlD
Escitalopram—SLC6A2—brainstem—multiple sclerosis	0.00129	0.0328	CbGeAlD
Escitalopram—ADRA1A—brainstem—multiple sclerosis	0.0012	0.0305	CbGeAlD
Escitalopram—HTR2C—medulla oblongata—multiple sclerosis	0.00108	0.0274	CbGeAlD
Escitalopram—SLC6A3—midbrain—multiple sclerosis	0.00102	0.0259	CbGeAlD
Escitalopram—SLC6A3—spinal cord—multiple sclerosis	0.000993	0.0253	CbGeAlD
Escitalopram—HTR2C—midbrain—multiple sclerosis	0.000984	0.025	CbGeAlD
Escitalopram—HTR2C—spinal cord—multiple sclerosis	0.00096	0.0244	CbGeAlD
Escitalopram—SLC6A4—midbrain—multiple sclerosis	0.000932	0.0237	CbGeAlD
Escitalopram—SLC6A4—spinal cord—multiple sclerosis	0.00091	0.0231	CbGeAlD
Escitalopram—SLC6A2—medulla oblongata—multiple sclerosis	0.000898	0.0229	CbGeAlD
Escitalopram—SLC6A3—nervous system—multiple sclerosis	0.000836	0.0213	CbGeAlD
Escitalopram—HTR2C—nervous system—multiple sclerosis	0.000809	0.0206	CbGeAlD
Escitalopram—SLC6A3—central nervous system—multiple sclerosis	0.000805	0.0205	CbGeAlD
Escitalopram—SLC6A3—cerebellum—multiple sclerosis	0.000787	0.02	CbGeAlD
Escitalopram—HTR2C—central nervous system—multiple sclerosis	0.000778	0.0198	CbGeAlD
Escitalopram—SLC6A4—nervous system—multiple sclerosis	0.000767	0.0195	CbGeAlD
Escitalopram—CHRM1—nervous system—multiple sclerosis	0.000764	0.0194	CbGeAlD
Escitalopram—SLC6A4—central nervous system—multiple sclerosis	0.000738	0.0188	CbGeAlD
Escitalopram—CHRM1—central nervous system—multiple sclerosis	0.000735	0.0187	CbGeAlD
Escitalopram—CYP2D6—brainstem—multiple sclerosis	0.000705	0.0179	CbGeAlD
Escitalopram—SLC6A2—nervous system—multiple sclerosis	0.000675	0.0172	CbGeAlD
Escitalopram—SLC6A2—central nervous system—multiple sclerosis	0.00065	0.0165	CbGeAlD
Escitalopram—SLC6A3—brain—multiple sclerosis	0.000639	0.0163	CbGeAlD
Escitalopram—ADRA1A—nervous system—multiple sclerosis	0.000627	0.016	CbGeAlD
Escitalopram—HTR2C—brain—multiple sclerosis	0.000618	0.0157	CbGeAlD
Escitalopram—ADRA1A—central nervous system—multiple sclerosis	0.000604	0.0154	CbGeAlD
Escitalopram—ADRA1A—cerebellum—multiple sclerosis	0.00059	0.015	CbGeAlD
Escitalopram—SLC6A4—brain—multiple sclerosis	0.000586	0.0149	CbGeAlD
Escitalopram—CHRM1—brain—multiple sclerosis	0.000584	0.0149	CbGeAlD
Escitalopram—SLC6A2—brain—multiple sclerosis	0.000516	0.0131	CbGeAlD
Escitalopram—HRH1—nervous system—multiple sclerosis	0.000486	0.0124	CbGeAlD
Escitalopram—ADRA1A—brain—multiple sclerosis	0.00048	0.0122	CbGeAlD
Escitalopram—HRH1—central nervous system—multiple sclerosis	0.000468	0.0119	CbGeAlD
Escitalopram—CYP3A4—nervous system—multiple sclerosis	0.000375	0.00956	CbGeAlD
Escitalopram—HRH1—brain—multiple sclerosis	0.000371	0.00945	CbGeAlD
Escitalopram—CYP2D6—nervous system—multiple sclerosis	0.000369	0.0094	CbGeAlD
Escitalopram—CYP3A4—central nervous system—multiple sclerosis	0.000362	0.0092	CbGeAlD
Escitalopram—CYP2D6—central nervous system—multiple sclerosis	0.000356	0.00905	CbGeAlD
Escitalopram—CYP2D6—cerebellum—multiple sclerosis	0.000348	0.00885	CbGeAlD
Escitalopram—CYP2D6—brain—multiple sclerosis	0.000282	0.00719	CbGeAlD
Escitalopram—Skin disorder—Methylprednisolone—multiple sclerosis	0.000148	0.000311	CcSEcCtD
Escitalopram—Erythema—Prednisone—multiple sclerosis	0.000148	0.000311	CcSEcCtD
Escitalopram—Malnutrition—Prednisone—multiple sclerosis	0.000148	0.000311	CcSEcCtD
Escitalopram—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000148	0.00031	CcSEcCtD
Escitalopram—Agranulocytosis—Methotrexate—multiple sclerosis	0.000147	0.00031	CcSEcCtD
Escitalopram—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000147	0.00031	CcSEcCtD
Escitalopram—Convulsion—Dexamethasone—multiple sclerosis	0.000147	0.000309	CcSEcCtD
Escitalopram—Convulsion—Betamethasone—multiple sclerosis	0.000147	0.000309	CcSEcCtD
Escitalopram—Hypertension—Dexamethasone—multiple sclerosis	0.000147	0.000308	CcSEcCtD
Escitalopram—Hypertension—Betamethasone—multiple sclerosis	0.000147	0.000308	CcSEcCtD
Escitalopram—Asthenia—Mitoxantrone—multiple sclerosis	0.000145	0.000305	CcSEcCtD
Escitalopram—Myalgia—Dexamethasone—multiple sclerosis	0.000144	0.000304	CcSEcCtD
Escitalopram—Myalgia—Betamethasone—multiple sclerosis	0.000144	0.000304	CcSEcCtD
Escitalopram—Anxiety—Betamethasone—multiple sclerosis	0.000144	0.000303	CcSEcCtD
Escitalopram—Anxiety—Dexamethasone—multiple sclerosis	0.000144	0.000303	CcSEcCtD
Escitalopram—Discomfort—Dexamethasone—multiple sclerosis	0.000143	0.0003	CcSEcCtD
Escitalopram—Discomfort—Betamethasone—multiple sclerosis	0.000143	0.0003	CcSEcCtD
Escitalopram—Haemoglobin—Methotrexate—multiple sclerosis	0.000143	0.0003	CcSEcCtD
Escitalopram—Hypotension—Methylprednisolone—multiple sclerosis	0.000142	0.000299	CcSEcCtD
Escitalopram—Pain—Prednisolone—multiple sclerosis	0.000142	0.000298	CcSEcCtD
Escitalopram—Haemorrhage—Methotrexate—multiple sclerosis	0.000142	0.000298	CcSEcCtD
Escitalopram—Hepatitis—Methotrexate—multiple sclerosis	0.000142	0.000298	CcSEcCtD
Escitalopram—Pharyngitis—Methotrexate—multiple sclerosis	0.000141	0.000296	CcSEcCtD
Escitalopram—Urinary tract disorder—Methotrexate—multiple sclerosis	0.00014	0.000295	CcSEcCtD
Escitalopram—Vision blurred—Prednisone—multiple sclerosis	0.000139	0.000293	CcSEcCtD
Escitalopram—Urethral disorder—Methotrexate—multiple sclerosis	0.000139	0.000292	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000139	0.000292	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000139	0.000292	CcSEcCtD
Escitalopram—Oedema—Betamethasone—multiple sclerosis	0.000138	0.000291	CcSEcCtD
Escitalopram—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000138	0.000291	CcSEcCtD
Escitalopram—Oedema—Dexamethasone—multiple sclerosis	0.000138	0.000291	CcSEcCtD
Escitalopram—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000138	0.000291	CcSEcCtD
Escitalopram—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000138	0.000291	CcSEcCtD
Escitalopram—Insomnia—Triamcinolone—multiple sclerosis	0.000138	0.00029	CcSEcCtD
Escitalopram—Insomnia—Methylprednisolone—multiple sclerosis	0.000138	0.00029	CcSEcCtD
Escitalopram—Infection—Dexamethasone—multiple sclerosis	0.000138	0.000289	CcSEcCtD
Escitalopram—Infection—Betamethasone—multiple sclerosis	0.000138	0.000289	CcSEcCtD
Escitalopram—Ill-defined disorder—Prednisone—multiple sclerosis	0.000137	0.000288	CcSEcCtD
Escitalopram—Paraesthesia—Triamcinolone—multiple sclerosis	0.000137	0.000288	CcSEcCtD
Escitalopram—Feeling abnormal—Prednisolone—multiple sclerosis	0.000137	0.000288	CcSEcCtD
Escitalopram—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000137	0.000288	CcSEcCtD
Escitalopram—Visual impairment—Methotrexate—multiple sclerosis	0.000137	0.000287	CcSEcCtD
Escitalopram—Anaemia—Prednisone—multiple sclerosis	0.000137	0.000287	CcSEcCtD
Escitalopram—Shock—Betamethasone—multiple sclerosis	0.000136	0.000286	CcSEcCtD
Escitalopram—Shock—Dexamethasone—multiple sclerosis	0.000136	0.000286	CcSEcCtD
Escitalopram—Dyspnoea—Triamcinolone—multiple sclerosis	0.000136	0.000286	CcSEcCtD
Escitalopram—Nervous system disorder—Betamethasone—multiple sclerosis	0.000136	0.000286	CcSEcCtD
Escitalopram—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000136	0.000286	CcSEcCtD
Escitalopram—Agitation—Prednisone—multiple sclerosis	0.000136	0.000286	CcSEcCtD
Escitalopram—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000136	0.000285	CcSEcCtD
Escitalopram—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000136	0.000285	CcSEcCtD
Escitalopram—Tachycardia—Dexamethasone—multiple sclerosis	0.000135	0.000284	CcSEcCtD
Escitalopram—Tachycardia—Betamethasone—multiple sclerosis	0.000135	0.000284	CcSEcCtD
Escitalopram—Angioedema—Prednisone—multiple sclerosis	0.000135	0.000284	CcSEcCtD
Escitalopram—Dyspepsia—Triamcinolone—multiple sclerosis	0.000134	0.000282	CcSEcCtD
Escitalopram—Erythema multiforme—Methotrexate—multiple sclerosis	0.000134	0.000282	CcSEcCtD
Escitalopram—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000134	0.000282	CcSEcCtD
Escitalopram—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000134	0.000281	CcSEcCtD
Escitalopram—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000134	0.000281	CcSEcCtD
Escitalopram—Malaise—Prednisone—multiple sclerosis	0.000133	0.00028	CcSEcCtD
Escitalopram—Vertigo—Prednisone—multiple sclerosis	0.000133	0.000279	CcSEcCtD
Escitalopram—Eye disorder—Methotrexate—multiple sclerosis	0.000133	0.000279	CcSEcCtD
Escitalopram—Syncope—Prednisone—multiple sclerosis	0.000133	0.000279	CcSEcCtD
Escitalopram—Tinnitus—Methotrexate—multiple sclerosis	0.000132	0.000278	CcSEcCtD
Escitalopram—Anorexia—Dexamethasone—multiple sclerosis	0.000132	0.000278	CcSEcCtD
Escitalopram—Anorexia—Betamethasone—multiple sclerosis	0.000132	0.000278	CcSEcCtD
Escitalopram—Urticaria—Prednisolone—multiple sclerosis	0.000132	0.000277	CcSEcCtD
Escitalopram—Cardiac disorder—Methotrexate—multiple sclerosis	0.000132	0.000277	CcSEcCtD
Escitalopram—Fatigue—Triamcinolone—multiple sclerosis	0.000132	0.000277	CcSEcCtD
Escitalopram—Fatigue—Methylprednisolone—multiple sclerosis	0.000131	0.000276	CcSEcCtD
Escitalopram—Pain—Triamcinolone—multiple sclerosis	0.000131	0.000274	CcSEcCtD
Escitalopram—Loss of consciousness—Prednisone—multiple sclerosis	0.00013	0.000273	CcSEcCtD
Escitalopram—Hypotension—Dexamethasone—multiple sclerosis	0.000129	0.000272	CcSEcCtD
Escitalopram—Hypotension—Betamethasone—multiple sclerosis	0.000129	0.000272	CcSEcCtD
Escitalopram—Angiopathy—Methotrexate—multiple sclerosis	0.000129	0.000271	CcSEcCtD
Escitalopram—Vomiting—Mitoxantrone—multiple sclerosis	0.000129	0.00027	CcSEcCtD
Escitalopram—Immune system disorder—Methotrexate—multiple sclerosis	0.000128	0.000269	CcSEcCtD
Escitalopram—Convulsion—Prednisone—multiple sclerosis	0.000128	0.000269	CcSEcCtD
Escitalopram—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000128	0.000269	CcSEcCtD
Escitalopram—Hypertension—Prednisone—multiple sclerosis	0.000128	0.000268	CcSEcCtD
Escitalopram—Rash—Mitoxantrone—multiple sclerosis	0.000128	0.000268	CcSEcCtD
Escitalopram—Dermatitis—Mitoxantrone—multiple sclerosis	0.000127	0.000268	CcSEcCtD
Escitalopram—Chills—Methotrexate—multiple sclerosis	0.000127	0.000268	CcSEcCtD
Escitalopram—Headache—Mitoxantrone—multiple sclerosis	0.000127	0.000266	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000126	0.000265	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000126	0.000265	CcSEcCtD
Escitalopram—Myalgia—Prednisone—multiple sclerosis	0.000126	0.000265	CcSEcCtD
Escitalopram—Arthralgia—Prednisone—multiple sclerosis	0.000126	0.000265	CcSEcCtD
Escitalopram—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000126	0.000264	CcSEcCtD
Escitalopram—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000126	0.000264	CcSEcCtD
Escitalopram—Anxiety—Prednisone—multiple sclerosis	0.000125	0.000264	CcSEcCtD
Escitalopram—Alopecia—Methotrexate—multiple sclerosis	0.000125	0.000264	CcSEcCtD
Escitalopram—Insomnia—Betamethasone—multiple sclerosis	0.000125	0.000263	CcSEcCtD
Escitalopram—Insomnia—Dexamethasone—multiple sclerosis	0.000125	0.000263	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000125	0.000263	CcSEcCtD
Escitalopram—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000125	0.000262	CcSEcCtD
Escitalopram—Paraesthesia—Dexamethasone—multiple sclerosis	0.000124	0.000261	CcSEcCtD
Escitalopram—Paraesthesia—Betamethasone—multiple sclerosis	0.000124	0.000261	CcSEcCtD
Escitalopram—Discomfort—Prednisone—multiple sclerosis	0.000124	0.000261	CcSEcCtD
Escitalopram—Mental disorder—Methotrexate—multiple sclerosis	0.000124	0.000261	CcSEcCtD
Escitalopram—Erythema—Methotrexate—multiple sclerosis	0.000124	0.00026	CcSEcCtD
Escitalopram—Malnutrition—Methotrexate—multiple sclerosis	0.000124	0.00026	CcSEcCtD
Escitalopram—Hypersensitivity—Prednisolone—multiple sclerosis	0.000122	0.000257	CcSEcCtD
Escitalopram—Dyspepsia—Betamethasone—multiple sclerosis	0.000122	0.000256	CcSEcCtD
Escitalopram—Dyspepsia—Dexamethasone—multiple sclerosis	0.000122	0.000256	CcSEcCtD
Escitalopram—Urticaria—Triamcinolone—multiple sclerosis	0.000121	0.000255	CcSEcCtD
Escitalopram—Urticaria—Methylprednisolone—multiple sclerosis	0.000121	0.000254	CcSEcCtD
Escitalopram—Dysgeusia—Methotrexate—multiple sclerosis	0.000121	0.000254	CcSEcCtD
Escitalopram—Body temperature increased—Triamcinolone—multiple sclerosis	0.000121	0.000254	CcSEcCtD
Escitalopram—Anaphylactic shock—Prednisone—multiple sclerosis	0.000121	0.000254	CcSEcCtD
Escitalopram—Oedema—Prednisone—multiple sclerosis	0.000121	0.000254	CcSEcCtD
Escitalopram—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00012	0.000253	CcSEcCtD
Escitalopram—Decreased appetite—Dexamethasone—multiple sclerosis	0.00012	0.000253	CcSEcCtD
Escitalopram—Decreased appetite—Betamethasone—multiple sclerosis	0.00012	0.000253	CcSEcCtD
Escitalopram—Nausea—Mitoxantrone—multiple sclerosis	0.00012	0.000253	CcSEcCtD
Escitalopram—Infection—Prednisone—multiple sclerosis	0.00012	0.000252	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00012	0.000251	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00012	0.000251	CcSEcCtD
Escitalopram—Back pain—Methotrexate—multiple sclerosis	0.000119	0.000251	CcSEcCtD
Escitalopram—Fatigue—Dexamethasone—multiple sclerosis	0.000119	0.000251	CcSEcCtD
Escitalopram—Fatigue—Betamethasone—multiple sclerosis	0.000119	0.000251	CcSEcCtD
Escitalopram—Shock—Prednisone—multiple sclerosis	0.000119	0.000249	CcSEcCtD
Escitalopram—Pain—Betamethasone—multiple sclerosis	0.000118	0.000249	CcSEcCtD
Escitalopram—Pain—Dexamethasone—multiple sclerosis	0.000118	0.000249	CcSEcCtD
Escitalopram—Nervous system disorder—Prednisone—multiple sclerosis	0.000118	0.000249	CcSEcCtD
Escitalopram—Tachycardia—Prednisone—multiple sclerosis	0.000118	0.000247	CcSEcCtD
Escitalopram—Skin disorder—Prednisone—multiple sclerosis	0.000117	0.000246	CcSEcCtD
Escitalopram—Hyperhidrosis—Prednisone—multiple sclerosis	0.000117	0.000245	CcSEcCtD
Escitalopram—Vision blurred—Methotrexate—multiple sclerosis	0.000116	0.000245	CcSEcCtD
Escitalopram—Anorexia—Prednisone—multiple sclerosis	0.000115	0.000242	CcSEcCtD
Escitalopram—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000115	0.000241	CcSEcCtD
Escitalopram—Anaemia—Methotrexate—multiple sclerosis	0.000114	0.00024	CcSEcCtD
Escitalopram—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000114	0.00024	CcSEcCtD
Escitalopram—Feeling abnormal—Betamethasone—multiple sclerosis	0.000114	0.00024	CcSEcCtD
Escitalopram—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000113	0.000238	CcSEcCtD
Escitalopram—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000113	0.000238	CcSEcCtD
Escitalopram—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000112	0.000236	CcSEcCtD
Escitalopram—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000112	0.000236	CcSEcCtD
Escitalopram—Malaise—Methotrexate—multiple sclerosis	0.000111	0.000234	CcSEcCtD
Escitalopram—Vertigo—Methotrexate—multiple sclerosis	0.000111	0.000233	CcSEcCtD
Escitalopram—Leukopenia—Methotrexate—multiple sclerosis	0.000111	0.000232	CcSEcCtD
Escitalopram—Urticaria—Dexamethasone—multiple sclerosis	0.00011	0.000231	CcSEcCtD
Escitalopram—Urticaria—Betamethasone—multiple sclerosis	0.00011	0.000231	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00011	0.000231	CcSEcCtD
Escitalopram—Dizziness—Prednisolone—multiple sclerosis	0.00011	0.000231	CcSEcCtD
Escitalopram—Asthenia—Triamcinolone—multiple sclerosis	0.00011	0.00023	CcSEcCtD
Escitalopram—Body temperature increased—Betamethasone—multiple sclerosis	0.000109	0.00023	CcSEcCtD
Escitalopram—Abdominal pain—Betamethasone—multiple sclerosis	0.000109	0.00023	CcSEcCtD
Escitalopram—Body temperature increased—Dexamethasone—multiple sclerosis	0.000109	0.00023	CcSEcCtD
Escitalopram—Abdominal pain—Dexamethasone—multiple sclerosis	0.000109	0.00023	CcSEcCtD
Escitalopram—Asthenia—Methylprednisolone—multiple sclerosis	0.000109	0.00023	CcSEcCtD
Escitalopram—Insomnia—Prednisone—multiple sclerosis	0.000109	0.000229	CcSEcCtD
Escitalopram—Paraesthesia—Prednisone—multiple sclerosis	0.000108	0.000228	CcSEcCtD
Escitalopram—Pruritus—Triamcinolone—multiple sclerosis	0.000108	0.000227	CcSEcCtD
Escitalopram—Cough—Methotrexate—multiple sclerosis	0.000108	0.000227	CcSEcCtD
Escitalopram—Pruritus—Methylprednisolone—multiple sclerosis	0.000108	0.000227	CcSEcCtD
Escitalopram—Convulsion—Methotrexate—multiple sclerosis	0.000107	0.000225	CcSEcCtD
Escitalopram—Dyspepsia—Prednisone—multiple sclerosis	0.000106	0.000223	CcSEcCtD
Escitalopram—Myalgia—Methotrexate—multiple sclerosis	0.000105	0.000221	CcSEcCtD
Escitalopram—Chest pain—Methotrexate—multiple sclerosis	0.000105	0.000221	CcSEcCtD
Escitalopram—Arthralgia—Methotrexate—multiple sclerosis	0.000105	0.000221	CcSEcCtD
Escitalopram—Decreased appetite—Prednisone—multiple sclerosis	0.000105	0.00022	CcSEcCtD
Escitalopram—Rash—Prednisolone—multiple sclerosis	0.000105	0.00022	CcSEcCtD
Escitalopram—Dermatitis—Prednisolone—multiple sclerosis	0.000105	0.00022	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000104	0.00022	CcSEcCtD
Escitalopram—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000104	0.000219	CcSEcCtD
Escitalopram—Fatigue—Prednisone—multiple sclerosis	0.000104	0.000219	CcSEcCtD
Escitalopram—Headache—Prednisolone—multiple sclerosis	0.000104	0.000219	CcSEcCtD
Escitalopram—Discomfort—Methotrexate—multiple sclerosis	0.000104	0.000218	CcSEcCtD
Escitalopram—Constipation—Prednisone—multiple sclerosis	0.000103	0.000217	CcSEcCtD
Escitalopram—Confusional state—Methotrexate—multiple sclerosis	0.000102	0.000214	CcSEcCtD
Escitalopram—Dizziness—Triamcinolone—multiple sclerosis	0.000101	0.000212	CcSEcCtD
Escitalopram—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000101	0.000212	CcSEcCtD
Escitalopram—Dizziness—Methylprednisolone—multiple sclerosis	0.000101	0.000212	CcSEcCtD
Escitalopram—Infection—Methotrexate—multiple sclerosis	0.0001	0.000211	CcSEcCtD
Escitalopram—Feeling abnormal—Prednisone—multiple sclerosis	9.94e-05	0.000209	CcSEcCtD
Escitalopram—Asthenia—Betamethasone—multiple sclerosis	9.94e-05	0.000209	CcSEcCtD
Escitalopram—Asthenia—Dexamethasone—multiple sclerosis	9.94e-05	0.000209	CcSEcCtD
Escitalopram—Nervous system disorder—Methotrexate—multiple sclerosis	9.89e-05	0.000208	CcSEcCtD
Escitalopram—Thrombocytopenia—Methotrexate—multiple sclerosis	9.87e-05	0.000207	CcSEcCtD
Escitalopram—Gastrointestinal pain—Prednisone—multiple sclerosis	9.86e-05	0.000207	CcSEcCtD
Escitalopram—Nausea—Prednisolone—multiple sclerosis	9.86e-05	0.000207	CcSEcCtD
Escitalopram—Pruritus—Dexamethasone—multiple sclerosis	9.8e-05	0.000206	CcSEcCtD
Escitalopram—Pruritus—Betamethasone—multiple sclerosis	9.8e-05	0.000206	CcSEcCtD
Escitalopram—Skin disorder—Methotrexate—multiple sclerosis	9.79e-05	0.000206	CcSEcCtD
Escitalopram—Hyperhidrosis—Methotrexate—multiple sclerosis	9.74e-05	0.000205	CcSEcCtD
Escitalopram—Vomiting—Triamcinolone—multiple sclerosis	9.71e-05	0.000204	CcSEcCtD
Escitalopram—Vomiting—Methylprednisolone—multiple sclerosis	9.68e-05	0.000204	CcSEcCtD
Escitalopram—Rash—Triamcinolone—multiple sclerosis	9.62e-05	0.000202	CcSEcCtD
Escitalopram—Dermatitis—Triamcinolone—multiple sclerosis	9.62e-05	0.000202	CcSEcCtD
Escitalopram—Anorexia—Methotrexate—multiple sclerosis	9.61e-05	0.000202	CcSEcCtD
Escitalopram—Rash—Methylprednisolone—multiple sclerosis	9.6e-05	0.000202	CcSEcCtD
Escitalopram—Dermatitis—Methylprednisolone—multiple sclerosis	9.59e-05	0.000202	CcSEcCtD
Escitalopram—Urticaria—Prednisone—multiple sclerosis	9.58e-05	0.000201	CcSEcCtD
Escitalopram—Headache—Triamcinolone—multiple sclerosis	9.56e-05	0.000201	CcSEcCtD
Escitalopram—Headache—Methylprednisolone—multiple sclerosis	9.54e-05	0.000201	CcSEcCtD
Escitalopram—Abdominal pain—Prednisone—multiple sclerosis	9.53e-05	0.0002	CcSEcCtD
Escitalopram—Body temperature increased—Prednisone—multiple sclerosis	9.53e-05	0.0002	CcSEcCtD
Escitalopram—Diarrhoea—Betamethasone—multiple sclerosis	9.48e-05	0.000199	CcSEcCtD
Escitalopram—Diarrhoea—Dexamethasone—multiple sclerosis	9.48e-05	0.000199	CcSEcCtD
Escitalopram—Hypotension—Methotrexate—multiple sclerosis	9.42e-05	0.000198	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	9.18e-05	0.000193	CcSEcCtD
Escitalopram—Dizziness—Dexamethasone—multiple sclerosis	9.16e-05	0.000193	CcSEcCtD
Escitalopram—Dizziness—Betamethasone—multiple sclerosis	9.16e-05	0.000193	CcSEcCtD
Escitalopram—Insomnia—Methotrexate—multiple sclerosis	9.12e-05	0.000192	CcSEcCtD
Escitalopram—Nausea—Triamcinolone—multiple sclerosis	9.07e-05	0.000191	CcSEcCtD
Escitalopram—Paraesthesia—Methotrexate—multiple sclerosis	9.05e-05	0.00019	CcSEcCtD
Escitalopram—Nausea—Methylprednisolone—multiple sclerosis	9.05e-05	0.00019	CcSEcCtD
Escitalopram—Dyspnoea—Methotrexate—multiple sclerosis	8.99e-05	0.000189	CcSEcCtD
Escitalopram—Somnolence—Methotrexate—multiple sclerosis	8.96e-05	0.000188	CcSEcCtD
Escitalopram—Hypersensitivity—Prednisone—multiple sclerosis	8.89e-05	0.000187	CcSEcCtD
Escitalopram—Dyspepsia—Methotrexate—multiple sclerosis	8.87e-05	0.000187	CcSEcCtD
Escitalopram—Vomiting—Betamethasone—multiple sclerosis	8.81e-05	0.000185	CcSEcCtD
Escitalopram—Vomiting—Dexamethasone—multiple sclerosis	8.81e-05	0.000185	CcSEcCtD
Escitalopram—Decreased appetite—Methotrexate—multiple sclerosis	8.76e-05	0.000184	CcSEcCtD
Escitalopram—Rash—Dexamethasone—multiple sclerosis	8.73e-05	0.000184	CcSEcCtD
Escitalopram—Rash—Betamethasone—multiple sclerosis	8.73e-05	0.000184	CcSEcCtD
Escitalopram—Dermatitis—Betamethasone—multiple sclerosis	8.72e-05	0.000183	CcSEcCtD
Escitalopram—Dermatitis—Dexamethasone—multiple sclerosis	8.72e-05	0.000183	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Methotrexate—multiple sclerosis	8.7e-05	0.000183	CcSEcCtD
Escitalopram—Fatigue—Methotrexate—multiple sclerosis	8.69e-05	0.000183	CcSEcCtD
Escitalopram—Headache—Dexamethasone—multiple sclerosis	8.68e-05	0.000182	CcSEcCtD
Escitalopram—Headache—Betamethasone—multiple sclerosis	8.68e-05	0.000182	CcSEcCtD
Escitalopram—Asthenia—Prednisone—multiple sclerosis	8.65e-05	0.000182	CcSEcCtD
Escitalopram—Pain—Methotrexate—multiple sclerosis	8.62e-05	0.000181	CcSEcCtD
Escitalopram—Pruritus—Prednisone—multiple sclerosis	8.53e-05	0.000179	CcSEcCtD
Escitalopram—Feeling abnormal—Methotrexate—multiple sclerosis	8.31e-05	0.000175	CcSEcCtD
Escitalopram—Diarrhoea—Prednisone—multiple sclerosis	8.25e-05	0.000173	CcSEcCtD
Escitalopram—Gastrointestinal pain—Methotrexate—multiple sclerosis	8.24e-05	0.000173	CcSEcCtD
Escitalopram—Nausea—Betamethasone—multiple sclerosis	8.23e-05	0.000173	CcSEcCtD
Escitalopram—Nausea—Dexamethasone—multiple sclerosis	8.23e-05	0.000173	CcSEcCtD
Escitalopram—Urticaria—Methotrexate—multiple sclerosis	8.01e-05	0.000168	CcSEcCtD
Escitalopram—Dizziness—Prednisone—multiple sclerosis	7.98e-05	0.000168	CcSEcCtD
Escitalopram—Abdominal pain—Methotrexate—multiple sclerosis	7.97e-05	0.000168	CcSEcCtD
Escitalopram—Body temperature increased—Methotrexate—multiple sclerosis	7.97e-05	0.000168	CcSEcCtD
Escitalopram—Vomiting—Prednisone—multiple sclerosis	7.67e-05	0.000161	CcSEcCtD
Escitalopram—Rash—Prednisone—multiple sclerosis	7.6e-05	0.00016	CcSEcCtD
Escitalopram—Dermatitis—Prednisone—multiple sclerosis	7.6e-05	0.00016	CcSEcCtD
Escitalopram—Headache—Prednisone—multiple sclerosis	7.56e-05	0.000159	CcSEcCtD
Escitalopram—Hypersensitivity—Methotrexate—multiple sclerosis	7.43e-05	0.000156	CcSEcCtD
Escitalopram—Asthenia—Methotrexate—multiple sclerosis	7.23e-05	0.000152	CcSEcCtD
Escitalopram—Nausea—Prednisone—multiple sclerosis	7.16e-05	0.000151	CcSEcCtD
Escitalopram—Pruritus—Methotrexate—multiple sclerosis	7.13e-05	0.00015	CcSEcCtD
Escitalopram—Diarrhoea—Methotrexate—multiple sclerosis	6.9e-05	0.000145	CcSEcCtD
Escitalopram—Dizziness—Methotrexate—multiple sclerosis	6.67e-05	0.00014	CcSEcCtD
Escitalopram—Vomiting—Methotrexate—multiple sclerosis	6.41e-05	0.000135	CcSEcCtD
Escitalopram—Rash—Methotrexate—multiple sclerosis	6.36e-05	0.000134	CcSEcCtD
Escitalopram—Dermatitis—Methotrexate—multiple sclerosis	6.35e-05	0.000133	CcSEcCtD
Escitalopram—Headache—Methotrexate—multiple sclerosis	6.31e-05	0.000133	CcSEcCtD
Escitalopram—Nausea—Methotrexate—multiple sclerosis	5.99e-05	0.000126	CcSEcCtD
Escitalopram—CHRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	3.22e-05	0.000758	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CXCR3—multiple sclerosis	3.17e-05	0.000746	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—CCL2—multiple sclerosis	3.16e-05	0.000744	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CCL3—multiple sclerosis	3.15e-05	0.000743	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCL3—multiple sclerosis	3.14e-05	0.00074	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CCR2—multiple sclerosis	3.14e-05	0.00074	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CCR2—multiple sclerosis	3.13e-05	0.000737	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCL3—multiple sclerosis	3.09e-05	0.000729	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CCR2—multiple sclerosis	3.08e-05	0.000726	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CNR1—multiple sclerosis	3.04e-05	0.000716	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—PTGER4—multiple sclerosis	3.04e-05	0.000715	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—PTGER4—multiple sclerosis	3.03e-05	0.000713	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCR1—multiple sclerosis	3.02e-05	0.000711	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CXCL13—multiple sclerosis	3.02e-05	0.000711	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RGS1—multiple sclerosis	3.02e-05	0.00071	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—CXCL10—multiple sclerosis	3.01e-05	0.000709	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RGS1—multiple sclerosis	3.01e-05	0.000708	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PTGER4—multiple sclerosis	2.98e-05	0.000702	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—RGS1—multiple sclerosis	2.96e-05	0.000697	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CXCR3—multiple sclerosis	2.93e-05	0.000691	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CXCR3—multiple sclerosis	2.92e-05	0.000688	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.91e-05	0.000686	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.91e-05	0.000686	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CNR1—multiple sclerosis	2.9e-05	0.000683	CbGpPWpGaD
Escitalopram—SLC6A3—Neuronal System—MAPK1—multiple sclerosis	2.89e-05	0.000681	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CNR1—multiple sclerosis	2.89e-05	0.000681	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CXCR3—multiple sclerosis	2.88e-05	0.000678	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—GPR65—multiple sclerosis	2.86e-05	0.000673	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CCR2—multiple sclerosis	2.85e-05	0.000672	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—GPR65—multiple sclerosis	2.85e-05	0.000671	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.85e-05	0.000671	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CNR1—multiple sclerosis	2.84e-05	0.00067	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCR2—multiple sclerosis	2.84e-05	0.00067	CbGpPWpGaD
Escitalopram—SLC6A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.83e-05	0.000666	CbGpPWpGaD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	2.81e-05	0.000661	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—GPR65—multiple sclerosis	2.8e-05	0.000661	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—POMC—multiple sclerosis	2.8e-05	0.000659	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCR2—multiple sclerosis	2.8e-05	0.000659	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	2.8e-05	0.000659	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	2.79e-05	0.000657	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	2.75e-05	0.000649	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—POMC—multiple sclerosis	2.75e-05	0.000647	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—CCL2—multiple sclerosis	2.74e-05	0.000645	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CXCL10—multiple sclerosis	2.73e-05	0.000644	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	2.73e-05	0.000643	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—CCL2—multiple sclerosis	2.69e-05	0.000633	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.68e-05	0.000631	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.68e-05	0.000631	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.66e-05	0.000628	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CNR1—multiple sclerosis	2.63e-05	0.00062	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	2.62e-05	0.000618	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCR1—multiple sclerosis	2.61e-05	0.000616	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CXCL13—multiple sclerosis	2.61e-05	0.000616	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CXCL10—multiple sclerosis	2.61e-05	0.000615	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	2.61e-05	0.000614	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	2.61e-05	0.000614	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	2.6e-05	0.000613	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—CCL5—multiple sclerosis	2.59e-05	0.000611	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CNR1—multiple sclerosis	2.58e-05	0.000608	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCR1—multiple sclerosis	2.57e-05	0.000604	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CXCL13—multiple sclerosis	2.57e-05	0.000604	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CXCL10—multiple sclerosis	2.56e-05	0.000603	CbGpPWpGaD
Escitalopram—SLC6A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.51e-05	0.00059	CbGpPWpGaD
Escitalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	2.49e-05	0.000586	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SRM—multiple sclerosis	2.49e-05	0.000586	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.45e-05	0.000577	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CXCL10—multiple sclerosis	2.37e-05	0.000558	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	2.36e-05	0.000556	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CCL5—multiple sclerosis	2.35e-05	0.000555	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—CCR5—multiple sclerosis	2.34e-05	0.00055	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	2.33e-05	0.000548	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.3e-05	0.000543	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—IL2RA—multiple sclerosis	2.3e-05	0.000542	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	2.27e-05	0.000534	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CCL5—multiple sclerosis	2.25e-05	0.000529	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	2.24e-05	0.000527	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.21e-05	0.00052	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	2.2e-05	0.000519	CbGpPWpGaD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	2.16e-05	0.000508	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCL3—multiple sclerosis	2.15e-05	0.000506	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	2.15e-05	0.000506	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CCR5—multiple sclerosis	2.12e-05	0.0005	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	2.12e-05	0.000499	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL2RA—multiple sclerosis	2.09e-05	0.000492	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PTGER4—multiple sclerosis	2.07e-05	0.000487	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CCL5—multiple sclerosis	2.04e-05	0.000481	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PGR—multiple sclerosis	2.04e-05	0.00048	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	2.03e-05	0.000479	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—RRM1—multiple sclerosis	2.03e-05	0.000478	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CCR5—multiple sclerosis	2.02e-05	0.000477	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	2.02e-05	0.000475	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	2e-05	0.000472	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CXCR3—multiple sclerosis	2e-05	0.000471	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—IL2RA—multiple sclerosis	1.99e-05	0.00047	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	1.99e-05	0.000468	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	1.99e-05	0.000468	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CD28—multiple sclerosis	1.98e-05	0.000466	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	1.96e-05	0.000461	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCR2—multiple sclerosis	1.94e-05	0.000458	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCL3—multiple sclerosis	1.86e-05	0.000439	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	1.86e-05	0.000437	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	1.84e-05	0.000433	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	1.83e-05	0.000432	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	1.83e-05	0.000431	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—POMC—multiple sclerosis	1.83e-05	0.00043	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	1.81e-05	0.000427	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	1.81e-05	0.000425	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	1.8e-05	0.000425	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CNR1—multiple sclerosis	1.79e-05	0.000423	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	1.79e-05	0.000422	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	1.79e-05	0.000421	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	1.78e-05	0.000419	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PGR—multiple sclerosis	1.77e-05	0.000416	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PGR—multiple sclerosis	1.76e-05	0.000415	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	1.76e-05	0.000415	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.75e-05	0.000413	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.75e-05	0.000413	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	1.73e-05	0.000408	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	1.73e-05	0.000408	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	1.73e-05	0.000407	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CD28—multiple sclerosis	1.72e-05	0.000404	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.71e-05	0.000404	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CD28—multiple sclerosis	1.71e-05	0.000403	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	1.7e-05	0.0004	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCR2—multiple sclerosis	1.68e-05	0.000397	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	1.68e-05	0.000397	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	1.68e-05	0.000396	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—POMC—multiple sclerosis	1.66e-05	0.00039	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	1.65e-05	0.000389	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CCL2—multiple sclerosis	1.62e-05	0.000382	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CXCL10—multiple sclerosis	1.62e-05	0.000381	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.6e-05	0.000378	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	1.58e-05	0.000373	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	1.58e-05	0.000371	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CNR1—multiple sclerosis	1.55e-05	0.000366	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	1.55e-05	0.000366	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	1.55e-05	0.000365	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	1.53e-05	0.000359	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—TYK2—multiple sclerosis	1.47e-05	0.000347	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.47e-05	0.000347	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—POMC—multiple sclerosis	1.44e-05	0.000338	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	1.43e-05	0.000337	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CD86—multiple sclerosis	1.41e-05	0.000333	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	1.41e-05	0.000332	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	1.41e-05	0.000331	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	1.4e-05	0.00033	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	1.4e-05	0.00033	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	1.4e-05	0.000329	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCL5—multiple sclerosis	1.39e-05	0.000328	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	1.38e-05	0.000325	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	1.37e-05	0.000324	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—IL2—multiple sclerosis	1.35e-05	0.000318	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.34e-05	0.000316	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.33e-05	0.000313	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	1.29e-05	0.000303	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	1.28e-05	0.000301	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	1.27e-05	0.0003	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.27e-05	0.000299	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	1.25e-05	0.000295	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	1.25e-05	0.000295	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	1.23e-05	0.000291	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	1.23e-05	0.000289	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CD86—multiple sclerosis	1.22e-05	0.000288	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CD86—multiple sclerosis	1.22e-05	0.000287	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCL5—multiple sclerosis	1.2e-05	0.000284	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	1.2e-05	0.000283	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	1.2e-05	0.000283	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	1.18e-05	0.000279	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	1.17e-05	0.000275	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.17e-05	0.000275	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	1.17e-05	0.000275	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	1.15e-05	0.00027	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APOE—multiple sclerosis	1.14e-05	0.000269	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SPP1—multiple sclerosis	1.12e-05	0.000263	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	1.11e-05	0.000262	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	1.1e-05	0.000258	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCR5—multiple sclerosis	1.09e-05	0.000256	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	1.08e-05	0.000255	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	1.07e-05	0.000252	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	1.07e-05	0.000251	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	1.07e-05	0.000251	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL2—multiple sclerosis	1.06e-05	0.00025	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	1.06e-05	0.000249	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	1.05e-05	0.000247	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	1.04e-05	0.000245	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CD80—multiple sclerosis	1.03e-05	0.000243	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOE—multiple sclerosis	9.88e-06	0.000233	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOE—multiple sclerosis	9.84e-06	0.000232	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—POMC—multiple sclerosis	9.79e-06	0.000231	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	9.69e-06	0.000228	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	9.58e-06	0.000226	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	9.37e-06	0.000221	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CD80—multiple sclerosis	8.93e-06	0.00021	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CD80—multiple sclerosis	8.9e-06	0.00021	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	8.76e-06	0.000206	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	8.7e-06	0.000205	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—POMC—multiple sclerosis	8.48e-06	0.0002	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—POMC—multiple sclerosis	8.46e-06	0.000199	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	8.33e-06	0.000196	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCL2—multiple sclerosis	8.3e-06	0.000196	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	8.27e-06	0.000195	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	8.15e-06	0.000192	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	8.12e-06	0.000191	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	8.1e-06	0.000191	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	7.97e-06	0.000188	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOE—multiple sclerosis	7.63e-06	0.00018	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.63e-06	0.00018	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TYK2—multiple sclerosis	7.54e-06	0.000178	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	7.51e-06	0.000177	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	7.4e-06	0.000174	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL2—multiple sclerosis	7.24e-06	0.000171	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	7.2e-06	0.00017	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOE—multiple sclerosis	7.02e-06	0.000165	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	6.85e-06	0.000161	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—POMC—multiple sclerosis	6.55e-06	0.000154	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL2—multiple sclerosis	6.27e-06	0.000148	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL2—multiple sclerosis	6.25e-06	0.000147	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6—multiple sclerosis	6.24e-06	0.000147	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	6.22e-06	0.000147	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	6.15e-06	0.000145	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	6.12e-06	0.000144	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	6.09e-06	0.000143	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—POMC—multiple sclerosis	6.03e-06	0.000142	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ALB—multiple sclerosis	5.98e-06	0.000141	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MMP9—multiple sclerosis	5.94e-06	0.00014	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	5.92e-06	0.000139	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	5.83e-06	0.000137	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MYC—multiple sclerosis	5.66e-06	0.000133	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	5.65e-06	0.000133	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	5.54e-06	0.00013	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ALB—multiple sclerosis	5.5e-06	0.000129	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—STAT3—multiple sclerosis	5.28e-06	0.000124	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	5.26e-06	0.000124	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	5.18e-06	0.000122	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MYC—multiple sclerosis	4.9e-06	0.000116	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	4.89e-06	0.000115	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MYC—multiple sclerosis	4.89e-06	0.000115	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	4.88e-06	0.000115	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	4.81e-06	0.000113	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	4.8e-06	0.000113	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	4.8e-06	0.000113	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	4.78e-06	0.000113	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	4.71e-06	0.000111	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOE—multiple sclerosis	4.59e-06	0.000108	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6—multiple sclerosis	4.25e-06	0.0001	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—POMC—multiple sclerosis	3.94e-06	9.28e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6—multiple sclerosis	3.69e-06	8.69e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6—multiple sclerosis	3.67e-06	8.66e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	3.62e-06	8.52e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALB—multiple sclerosis	3.59e-06	8.46e-05	CbGpPWpGaD
